» Articles » PMID: 8662521

Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene Immunization

Overview
Journal Science
Specialty Science
Date 1996 Jul 19
PMID 8662521
Citations 179
Authors
Affiliations
Soon will be listed here.
Abstract

Vaccination with naked DNA elicits cellular and humoral immune responses that have a T helper cell type 1 bias. However, plasmid vectors expressing large amounts of gene product do not necessarily induce immune responses to the encoded antigens. Instead, the immunogenicity of plasmid DNA (pDNA) requires short immunostimulatory DNA sequences (ISS) that contain a CpG dinucleotide in a particular base context. Human monocytes transfected with pDNA or double-stranded oligonucleotides containing the ISS, but not those transfected with ISS-deficient pDNA or oligonucleotides, transcribed large amounts of interferon-alpha, interferon-beta, and interleukin-12. Although ISS are necessary for gene vaccination, they down-regulate gene expression and thus may interfere with gene replacement therapy by inducing proinflammatory cytokines.

Citing Articles

Innate Sensing of Viral Nucleic Acids and Their Use in Antiviral Vaccine Development.

Enya T, Ross S Vaccines (Basel). 2025; 13(2).

PMID: 40006739 PMC: 11860339. DOI: 10.3390/vaccines13020193.


DNA vaccines against GPRC5D synergize with PD-1 blockade to treat multiple myeloma.

Neeli P, Maza P, Chai D, Zhao D, Hoi X, Chan K NPJ Vaccines. 2024; 9(1):180.

PMID: 39353958 PMC: 11445568. DOI: 10.1038/s41541-024-00979-w.


Stowaways in the cargo: Contaminating nucleic acids in rAAV preparations for gene therapy.

Brimble M, Winston S, Davidoff A Mol Ther. 2023; 31(10):2826-2838.

PMID: 37533254 PMC: 10556190. DOI: 10.1016/j.ymthe.2023.07.025.


Evaluation of DNA Vaccine Candidates against Foot-and-Mouth Disease Virus in Cattle.

Puckette M, Clark B, Barrera J, Neilan J, Rasmussen M Vaccines (Basel). 2023; 11(2).

PMID: 36851264 PMC: 9960313. DOI: 10.3390/vaccines11020386.


A first-in-human phase 1 study of cavrotolimod, a TLR9 agonist spherical nucleic acid, in healthy participants: Evidence of immune activation.

Daniel W, Lorch U, Mix S, Bexon A Front Immunol. 2022; 13:1073777.

PMID: 36582243 PMC: 9792500. DOI: 10.3389/fimmu.2022.1073777.